Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Echinococcus multilocularis | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Brugia malayi | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Gamma tubulin | 0.0015 | 0 | 0.5 |
Mycobacterium ulcerans | L-lysine aminotransferase | 0.0269 | 0.9377 | 1 |
Trypanosoma cruzi | epsilon tubulin, putative | 0.0015 | 0 | 0.5 |
Brugia malayi | 4-aminobutyrate aminotransferase, mitochondrial precursor | 0.0269 | 0.9377 | 0.9377 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Mycobacterium leprae | Probable Acetylornithine aminotransferase ArgD | 0.0024 | 0.0325 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.1593 | 1 |
Entamoeba histolytica | tubulin family protein | 0.0015 | 0 | 0.5 |
Chlamydia trachomatis | glutamate-1-semialdehyde-2,1-aminomutase | 0.0024 | 0.0325 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0015 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 1 | 1 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Giardia lamblia | Alpha-tubulin | 0.0015 | 0 | 0.5 |
Schistosoma mansoni | ornithine--oxo-acid transaminase | 0.0024 | 0.0325 | 0.2039 |
Trypanosoma brucei | beta tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | alpha tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma cruzi | alpha tubulin, putative | 0.0015 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Giardia lamblia | Alpha-tubulin | 0.0015 | 0 | 0.5 |
Entamoeba histolytica | tubulin gamma chain | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | alpha tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | tubulin gamma chain | 0.0015 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Plasmodium vivax | ornithine aminotransferase, putative | 0.0024 | 0.0325 | 1 |
Mycobacterium tuberculosis | Probable L-lysine-epsilon aminotransferase Lat (L-lysine aminotransferase) (lysine 6-aminotransferase) | 0.0269 | 0.9377 | 1 |
Toxoplasma gondii | ornithine aminotransferase, mitochondrial precursor, putative | 0.0024 | 0.0325 | 1 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | alpha tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Plasmodium falciparum | ornithine aminotransferase | 0.0024 | 0.0325 | 1 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0024 | 0.0325 | 0.0325 |
Leishmania major | epsilon tubulin, putative | 0.0015 | 0 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma cruzi | epsilon tubulin, putative | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Entamoeba histolytica | tubulin alpha chain, putative | 0.0015 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0024 | 0.0325 | 0.0325 |
Echinococcus granulosus | ornithine aminotransferase | 0.0024 | 0.0325 | 0.0325 |
Entamoeba histolytica | tubulin alpha-1 chain | 0.0015 | 0 | 0.5 |
Trypanosoma cruzi | beta tubulin, putative | 0.0015 | 0 | 0.5 |
Echinococcus granulosus | Aminotransferase class III | 0.0024 | 0.0325 | 0.0325 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | epsilon tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | gamma-tubulin | 0.0015 | 0 | 0.5 |
Entamoeba histolytica | tubulin family protein | 0.0015 | 0 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0015 | 0 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 1 | 1 |
Trypanosoma brucei | beta tubulin | 0.0015 | 0 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0015 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | acetylornithine transaminase protein | 0.0024 | 0.0325 | 0.5 |
Onchocerca volvulus | 0.0058 | 0.1593 | 0.5 | |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.0024 | 0.0325 | 1 |
Trypanosoma brucei | alpha tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma cruzi | tubulin gamma chain | 0.0015 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE HEML (GSA) (GLUTAMATE-1-SEMIALDEHYDE AMINOTRANSFERASE) (GSA-AT) | 0.0024 | 0.0325 | 0.5 |
Trypanosoma brucei | epsilon tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Echinococcus multilocularis | Aminotransferase class III | 0.0024 | 0.0325 | 0.0325 |
Mycobacterium leprae | PROBABLE ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRANSFERASE BIOA | 0.0024 | 0.0325 | 0.5 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | epsilon tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.1593 | 0.1593 |
Mycobacterium leprae | Probable 4-aminobutyrate aminotransferase GabT (GAMMA-AMINO-N-BUTYRATE TRANSAMINASE) (GABA TRANSAMINASE) (GLUTAMATE:SUCCINIC SEM | 0.0024 | 0.0325 | 0.5 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.1593 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 1 | 1 |
Leishmania major | alpha tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0015 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | Activation of SMN expressed in HEK293 cells assessed as concentration required to reach 50% of maximum luciferase signal by SMN2-promotor driven luciferase reporter gene assay | ChEMBL. | 21819082 | |
Potency (functional) | 5.4679 uM | PUBCHEM_BIOASSAY: Confirmation Concentration-Response Assay for Enhancers of SMN2 Splice Variant Expression for Further Probe SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1474] | ChEMBL. | No reference |
Potency (functional) | 89.7249 uM | PUBCHEM_BIOASSAY: Counterscreen Assay for Enhancers of SMN2 Splice Variant Expression: Interaction with Luciferase Reporter for Further Probe SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1474] | ChEMBL. | No reference |
Potency (functional) | 30748.2558 uM | PUBCHEM_BIOASSAY: Counterscreen Assay for Enhancers of SMN2 Splice Variant Expression: Modulation of SMN1 Expression for Further Probe SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1474] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.